nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamotrigine—ABCB1—ovarian cancer	0.486	1	CbGaD
Lamotrigine—ABCB1—Topotecan—ovarian cancer	0.0288	0.354	CbGbCtD
Lamotrigine—ABCB1—Vinorelbine—ovarian cancer	0.0203	0.25	CbGbCtD
Lamotrigine—ABCB1—Paclitaxel—ovarian cancer	0.0142	0.175	CbGbCtD
Lamotrigine—ABCB1—Docetaxel—ovarian cancer	0.0103	0.127	CbGbCtD
Lamotrigine—ABCB1—Doxorubicin—ovarian cancer	0.00767	0.0945	CbGbCtD
Lamotrigine—Chest pain—Docetaxel—ovarian cancer	0.000205	0.000485	CcSEcCtD
Lamotrigine—Myalgia—Docetaxel—ovarian cancer	0.000205	0.000485	CcSEcCtD
Lamotrigine—Arthralgia—Docetaxel—ovarian cancer	0.000205	0.000485	CcSEcCtD
Lamotrigine—Pancytopenia—Doxorubicin—ovarian cancer	0.000205	0.000485	CcSEcCtD
Lamotrigine—Nausea—Vinorelbine—ovarian cancer	0.000205	0.000485	CcSEcCtD
Lamotrigine—Renal failure—Epirubicin—ovarian cancer	0.000204	0.000483	CcSEcCtD
Lamotrigine—Dyspepsia—Paclitaxel—ovarian cancer	0.000204	0.000483	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000204	0.000482	CcSEcCtD
Lamotrigine—Stomatitis—Epirubicin—ovarian cancer	0.000203	0.000479	CcSEcCtD
Lamotrigine—Conjunctivitis—Epirubicin—ovarian cancer	0.000202	0.000478	CcSEcCtD
Lamotrigine—Urinary tract infection—Epirubicin—ovarian cancer	0.000202	0.000478	CcSEcCtD
Lamotrigine—Dysuria—Doxorubicin—ovarian cancer	0.000202	0.000477	CcSEcCtD
Lamotrigine—Neutropenia—Doxorubicin—ovarian cancer	0.000202	0.000477	CcSEcCtD
Lamotrigine—Decreased appetite—Paclitaxel—ovarian cancer	0.000202	0.000477	CcSEcCtD
Lamotrigine—Dry mouth—Docetaxel—ovarian cancer	0.0002	0.000474	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.0002	0.000474	CcSEcCtD
Lamotrigine—Fatigue—Paclitaxel—ovarian cancer	0.0002	0.000473	CcSEcCtD
Lamotrigine—Sweating—Epirubicin—ovarian cancer	0.000199	0.000472	CcSEcCtD
Lamotrigine—Pollakiuria—Doxorubicin—ovarian cancer	0.000199	0.000472	CcSEcCtD
Lamotrigine—Pain—Paclitaxel—ovarian cancer	0.000198	0.000469	CcSEcCtD
Lamotrigine—Constipation—Paclitaxel—ovarian cancer	0.000198	0.000469	CcSEcCtD
Lamotrigine—Haematuria—Epirubicin—ovarian cancer	0.000198	0.000469	CcSEcCtD
Lamotrigine—Confusional state—Docetaxel—ovarian cancer	0.000198	0.000469	CcSEcCtD
Lamotrigine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000197	0.000466	CcSEcCtD
Lamotrigine—Oedema—Docetaxel—ovarian cancer	0.000196	0.000465	CcSEcCtD
Lamotrigine—Weight increased—Doxorubicin—ovarian cancer	0.000196	0.000465	CcSEcCtD
Lamotrigine—Epistaxis—Epirubicin—ovarian cancer	0.000196	0.000464	CcSEcCtD
Lamotrigine—Infection—Docetaxel—ovarian cancer	0.000195	0.000462	CcSEcCtD
Lamotrigine—Weight decreased—Doxorubicin—ovarian cancer	0.000195	0.000462	CcSEcCtD
Lamotrigine—Sinusitis—Epirubicin—ovarian cancer	0.000195	0.000461	CcSEcCtD
Lamotrigine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000195	0.00046	CcSEcCtD
Lamotrigine—Agranulocytosis—Epirubicin—ovarian cancer	0.000194	0.000459	CcSEcCtD
Lamotrigine—Pneumonia—Doxorubicin—ovarian cancer	0.000193	0.000458	CcSEcCtD
Lamotrigine—Shock—Docetaxel—ovarian cancer	0.000193	0.000458	CcSEcCtD
Lamotrigine—Nervous system disorder—Docetaxel—ovarian cancer	0.000193	0.000456	CcSEcCtD
Lamotrigine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000192	0.000455	CcSEcCtD
Lamotrigine—Infestation—Doxorubicin—ovarian cancer	0.000192	0.000455	CcSEcCtD
Lamotrigine—Drowsiness—Doxorubicin—ovarian cancer	0.000192	0.000455	CcSEcCtD
Lamotrigine—Infestation NOS—Doxorubicin—ovarian cancer	0.000192	0.000455	CcSEcCtD
Lamotrigine—Tachycardia—Docetaxel—ovarian cancer	0.000192	0.000454	CcSEcCtD
Lamotrigine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000191	0.000452	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000191	0.000451	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00019	0.000449	CcSEcCtD
Lamotrigine—Renal failure—Doxorubicin—ovarian cancer	0.000189	0.000447	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000188	0.000446	CcSEcCtD
Lamotrigine—Haemoglobin—Epirubicin—ovarian cancer	0.000187	0.000444	CcSEcCtD
Lamotrigine—Stomatitis—Doxorubicin—ovarian cancer	0.000187	0.000444	CcSEcCtD
Lamotrigine—Anorexia—Docetaxel—ovarian cancer	0.000187	0.000443	CcSEcCtD
Lamotrigine—Rhinitis—Epirubicin—ovarian cancer	0.000187	0.000443	CcSEcCtD
Lamotrigine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000187	0.000442	CcSEcCtD
Lamotrigine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000187	0.000442	CcSEcCtD
Lamotrigine—Hepatitis—Epirubicin—ovarian cancer	0.000187	0.000442	CcSEcCtD
Lamotrigine—Haemorrhage—Epirubicin—ovarian cancer	0.000187	0.000442	CcSEcCtD
Lamotrigine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000186	0.000439	CcSEcCtD
Lamotrigine—Pharyngitis—Epirubicin—ovarian cancer	0.000185	0.000438	CcSEcCtD
Lamotrigine—Sweating—Doxorubicin—ovarian cancer	0.000184	0.000436	CcSEcCtD
Lamotrigine—Urticaria—Paclitaxel—ovarian cancer	0.000184	0.000436	CcSEcCtD
Lamotrigine—Oedema peripheral—Epirubicin—ovarian cancer	0.000184	0.000435	CcSEcCtD
Lamotrigine—Haematuria—Doxorubicin—ovarian cancer	0.000183	0.000434	CcSEcCtD
Lamotrigine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000183	0.000434	CcSEcCtD
Lamotrigine—Abdominal pain—Paclitaxel—ovarian cancer	0.000183	0.000434	CcSEcCtD
Lamotrigine—Body temperature increased—Paclitaxel—ovarian cancer	0.000183	0.000434	CcSEcCtD
Lamotrigine—Epistaxis—Doxorubicin—ovarian cancer	0.000181	0.000429	CcSEcCtD
Lamotrigine—Sinusitis—Doxorubicin—ovarian cancer	0.00018	0.000427	CcSEcCtD
Lamotrigine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000179	0.000425	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000179	0.000424	CcSEcCtD
Lamotrigine—Insomnia—Docetaxel—ovarian cancer	0.000178	0.000421	CcSEcCtD
Lamotrigine—Paraesthesia—Docetaxel—ovarian cancer	0.000176	0.000418	CcSEcCtD
Lamotrigine—Erythema multiforme—Epirubicin—ovarian cancer	0.000176	0.000417	CcSEcCtD
Lamotrigine—Dyspnoea—Docetaxel—ovarian cancer	0.000175	0.000415	CcSEcCtD
Lamotrigine—Somnolence—Docetaxel—ovarian cancer	0.000175	0.000413	CcSEcCtD
Lamotrigine—Eye disorder—Epirubicin—ovarian cancer	0.000174	0.000413	CcSEcCtD
Lamotrigine—Tinnitus—Epirubicin—ovarian cancer	0.000174	0.000412	CcSEcCtD
Lamotrigine—Haemoglobin—Doxorubicin—ovarian cancer	0.000173	0.000411	CcSEcCtD
Lamotrigine—Flushing—Epirubicin—ovarian cancer	0.000173	0.00041	CcSEcCtD
Lamotrigine—Rhinitis—Doxorubicin—ovarian cancer	0.000173	0.00041	CcSEcCtD
Lamotrigine—Dyspepsia—Docetaxel—ovarian cancer	0.000173	0.000409	CcSEcCtD
Lamotrigine—Haemorrhage—Doxorubicin—ovarian cancer	0.000173	0.000409	CcSEcCtD
Lamotrigine—Hepatitis—Doxorubicin—ovarian cancer	0.000173	0.000409	CcSEcCtD
Lamotrigine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000172	0.000406	CcSEcCtD
Lamotrigine—Pharyngitis—Doxorubicin—ovarian cancer	0.000171	0.000405	CcSEcCtD
Lamotrigine—Decreased appetite—Docetaxel—ovarian cancer	0.000171	0.000404	CcSEcCtD
Lamotrigine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000171	0.000404	CcSEcCtD
Lamotrigine—Oedema peripheral—Doxorubicin—ovarian cancer	0.00017	0.000402	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00017	0.000402	CcSEcCtD
Lamotrigine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00017	0.000401	CcSEcCtD
Lamotrigine—Fatigue—Docetaxel—ovarian cancer	0.000169	0.000401	CcSEcCtD
Lamotrigine—Angiopathy—Epirubicin—ovarian cancer	0.000169	0.000401	CcSEcCtD
Lamotrigine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000168	0.000398	CcSEcCtD
Lamotrigine—Pain—Docetaxel—ovarian cancer	0.000168	0.000398	CcSEcCtD
Lamotrigine—Constipation—Docetaxel—ovarian cancer	0.000168	0.000398	CcSEcCtD
Lamotrigine—Chills—Epirubicin—ovarian cancer	0.000167	0.000396	CcSEcCtD
Lamotrigine—Asthenia—Paclitaxel—ovarian cancer	0.000166	0.000394	CcSEcCtD
Lamotrigine—Alopecia—Epirubicin—ovarian cancer	0.000165	0.00039	CcSEcCtD
Lamotrigine—Pruritus—Paclitaxel—ovarian cancer	0.000164	0.000388	CcSEcCtD
Lamotrigine—Mental disorder—Epirubicin—ovarian cancer	0.000163	0.000387	CcSEcCtD
Lamotrigine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000163	0.000386	CcSEcCtD
Lamotrigine—Erythema—Epirubicin—ovarian cancer	0.000162	0.000384	CcSEcCtD
Lamotrigine—Malnutrition—Epirubicin—ovarian cancer	0.000162	0.000384	CcSEcCtD
Lamotrigine—Feeling abnormal—Docetaxel—ovarian cancer	0.000162	0.000383	CcSEcCtD
Lamotrigine—Eye disorder—Doxorubicin—ovarian cancer	0.000161	0.000382	CcSEcCtD
Lamotrigine—Tinnitus—Doxorubicin—ovarian cancer	0.000161	0.000381	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000161	0.00038	CcSEcCtD
Lamotrigine—Flushing—Doxorubicin—ovarian cancer	0.00016	0.000379	CcSEcCtD
Lamotrigine—Flatulence—Epirubicin—ovarian cancer	0.00016	0.000379	CcSEcCtD
Lamotrigine—Tension—Epirubicin—ovarian cancer	0.000159	0.000377	CcSEcCtD
Lamotrigine—Dysgeusia—Epirubicin—ovarian cancer	0.000159	0.000376	CcSEcCtD
Lamotrigine—Diarrhoea—Paclitaxel—ovarian cancer	0.000159	0.000375	CcSEcCtD
Lamotrigine—Nervousness—Epirubicin—ovarian cancer	0.000158	0.000373	CcSEcCtD
Lamotrigine—Back pain—Epirubicin—ovarian cancer	0.000157	0.000372	CcSEcCtD
Lamotrigine—Angiopathy—Doxorubicin—ovarian cancer	0.000157	0.000371	CcSEcCtD
Lamotrigine—Muscle spasms—Epirubicin—ovarian cancer	0.000156	0.00037	CcSEcCtD
Lamotrigine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000156	0.000368	CcSEcCtD
Lamotrigine—Body temperature increased—Docetaxel—ovarian cancer	0.000155	0.000368	CcSEcCtD
Lamotrigine—Abdominal pain—Docetaxel—ovarian cancer	0.000155	0.000368	CcSEcCtD
Lamotrigine—Chills—Doxorubicin—ovarian cancer	0.000155	0.000367	CcSEcCtD
Lamotrigine—Dizziness—Paclitaxel—ovarian cancer	0.000153	0.000363	CcSEcCtD
Lamotrigine—Vision blurred—Epirubicin—ovarian cancer	0.000153	0.000362	CcSEcCtD
Lamotrigine—Alopecia—Doxorubicin—ovarian cancer	0.000153	0.000361	CcSEcCtD
Lamotrigine—Mental disorder—Doxorubicin—ovarian cancer	0.000151	0.000358	CcSEcCtD
Lamotrigine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000151	0.000357	CcSEcCtD
Lamotrigine—Erythema—Doxorubicin—ovarian cancer	0.00015	0.000356	CcSEcCtD
Lamotrigine—Malnutrition—Doxorubicin—ovarian cancer	0.00015	0.000356	CcSEcCtD
Lamotrigine—Anaemia—Epirubicin—ovarian cancer	0.00015	0.000355	CcSEcCtD
Lamotrigine—Agitation—Epirubicin—ovarian cancer	0.000149	0.000353	CcSEcCtD
Lamotrigine—Flatulence—Doxorubicin—ovarian cancer	0.000148	0.00035	CcSEcCtD
Lamotrigine—Tension—Doxorubicin—ovarian cancer	0.000147	0.000349	CcSEcCtD
Lamotrigine—Vomiting—Paclitaxel—ovarian cancer	0.000147	0.000349	CcSEcCtD
Lamotrigine—Dysgeusia—Doxorubicin—ovarian cancer	0.000147	0.000348	CcSEcCtD
Lamotrigine—Malaise—Epirubicin—ovarian cancer	0.000146	0.000347	CcSEcCtD
Lamotrigine—Rash—Paclitaxel—ovarian cancer	0.000146	0.000346	CcSEcCtD
Lamotrigine—Dermatitis—Paclitaxel—ovarian cancer	0.000146	0.000346	CcSEcCtD
Lamotrigine—Nervousness—Doxorubicin—ovarian cancer	0.000146	0.000345	CcSEcCtD
Lamotrigine—Vertigo—Epirubicin—ovarian cancer	0.000146	0.000345	CcSEcCtD
Lamotrigine—Syncope—Epirubicin—ovarian cancer	0.000146	0.000345	CcSEcCtD
Lamotrigine—Leukopenia—Epirubicin—ovarian cancer	0.000145	0.000344	CcSEcCtD
Lamotrigine—Back pain—Doxorubicin—ovarian cancer	0.000145	0.000344	CcSEcCtD
Lamotrigine—Headache—Paclitaxel—ovarian cancer	0.000145	0.000344	CcSEcCtD
Lamotrigine—Hypersensitivity—Docetaxel—ovarian cancer	0.000145	0.000343	CcSEcCtD
Lamotrigine—Muscle spasms—Doxorubicin—ovarian cancer	0.000144	0.000342	CcSEcCtD
Lamotrigine—Palpitations—Epirubicin—ovarian cancer	0.000143	0.00034	CcSEcCtD
Lamotrigine—Loss of consciousness—Epirubicin—ovarian cancer	0.000143	0.000338	CcSEcCtD
Lamotrigine—Cough—Epirubicin—ovarian cancer	0.000142	0.000335	CcSEcCtD
Lamotrigine—Vision blurred—Doxorubicin—ovarian cancer	0.000142	0.000335	CcSEcCtD
Lamotrigine—Asthenia—Docetaxel—ovarian cancer	0.000141	0.000334	CcSEcCtD
Lamotrigine—Convulsion—Epirubicin—ovarian cancer	0.000141	0.000333	CcSEcCtD
Lamotrigine—Hypertension—Epirubicin—ovarian cancer	0.00014	0.000332	CcSEcCtD
Lamotrigine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000139	0.00033	CcSEcCtD
Lamotrigine—Pruritus—Docetaxel—ovarian cancer	0.000139	0.000329	CcSEcCtD
Lamotrigine—Anaemia—Doxorubicin—ovarian cancer	0.000139	0.000329	CcSEcCtD
Lamotrigine—Chest pain—Epirubicin—ovarian cancer	0.000138	0.000327	CcSEcCtD
Lamotrigine—Arthralgia—Epirubicin—ovarian cancer	0.000138	0.000327	CcSEcCtD
Lamotrigine—Myalgia—Epirubicin—ovarian cancer	0.000138	0.000327	CcSEcCtD
Lamotrigine—Agitation—Doxorubicin—ovarian cancer	0.000138	0.000327	CcSEcCtD
Lamotrigine—Anxiety—Epirubicin—ovarian cancer	0.000138	0.000326	CcSEcCtD
Lamotrigine—Nausea—Paclitaxel—ovarian cancer	0.000138	0.000326	CcSEcCtD
Lamotrigine—Discomfort—Epirubicin—ovarian cancer	0.000137	0.000323	CcSEcCtD
Lamotrigine—Malaise—Doxorubicin—ovarian cancer	0.000135	0.000321	CcSEcCtD
Lamotrigine—Dry mouth—Epirubicin—ovarian cancer	0.000135	0.00032	CcSEcCtD
Lamotrigine—Vertigo—Doxorubicin—ovarian cancer	0.000135	0.00032	CcSEcCtD
Lamotrigine—Syncope—Doxorubicin—ovarian cancer	0.000135	0.000319	CcSEcCtD
Lamotrigine—Leukopenia—Doxorubicin—ovarian cancer	0.000134	0.000318	CcSEcCtD
Lamotrigine—Diarrhoea—Docetaxel—ovarian cancer	0.000134	0.000318	CcSEcCtD
Lamotrigine—Confusional state—Epirubicin—ovarian cancer	0.000134	0.000316	CcSEcCtD
Lamotrigine—Palpitations—Doxorubicin—ovarian cancer	0.000133	0.000314	CcSEcCtD
Lamotrigine—Oedema—Epirubicin—ovarian cancer	0.000133	0.000314	CcSEcCtD
Lamotrigine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000132	0.000313	CcSEcCtD
Lamotrigine—Infection—Epirubicin—ovarian cancer	0.000132	0.000312	CcSEcCtD
Lamotrigine—Cough—Doxorubicin—ovarian cancer	0.000131	0.00031	CcSEcCtD
Lamotrigine—Shock—Epirubicin—ovarian cancer	0.00013	0.000309	CcSEcCtD
Lamotrigine—Convulsion—Doxorubicin—ovarian cancer	0.00013	0.000308	CcSEcCtD
Lamotrigine—Nervous system disorder—Epirubicin—ovarian cancer	0.00013	0.000308	CcSEcCtD
Lamotrigine—Dizziness—Docetaxel—ovarian cancer	0.00013	0.000308	CcSEcCtD
Lamotrigine—Thrombocytopenia—Epirubicin—ovarian cancer	0.00013	0.000307	CcSEcCtD
Lamotrigine—Hypertension—Doxorubicin—ovarian cancer	0.00013	0.000307	CcSEcCtD
Lamotrigine—Tachycardia—Epirubicin—ovarian cancer	0.000129	0.000306	CcSEcCtD
Lamotrigine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000128	0.000303	CcSEcCtD
Lamotrigine—Myalgia—Doxorubicin—ovarian cancer	0.000128	0.000303	CcSEcCtD
Lamotrigine—Arthralgia—Doxorubicin—ovarian cancer	0.000128	0.000303	CcSEcCtD
Lamotrigine—Chest pain—Doxorubicin—ovarian cancer	0.000128	0.000303	CcSEcCtD
Lamotrigine—Anxiety—Doxorubicin—ovarian cancer	0.000127	0.000302	CcSEcCtD
Lamotrigine—Discomfort—Doxorubicin—ovarian cancer	0.000126	0.000299	CcSEcCtD
Lamotrigine—Anorexia—Epirubicin—ovarian cancer	0.000126	0.000299	CcSEcCtD
Lamotrigine—Dry mouth—Doxorubicin—ovarian cancer	0.000125	0.000296	CcSEcCtD
Lamotrigine—Vomiting—Docetaxel—ovarian cancer	0.000125	0.000296	CcSEcCtD
Lamotrigine—Rash—Docetaxel—ovarian cancer	0.000124	0.000293	CcSEcCtD
Lamotrigine—Dermatitis—Docetaxel—ovarian cancer	0.000124	0.000293	CcSEcCtD
Lamotrigine—Confusional state—Doxorubicin—ovarian cancer	0.000124	0.000293	CcSEcCtD
Lamotrigine—Headache—Docetaxel—ovarian cancer	0.000123	0.000291	CcSEcCtD
Lamotrigine—Oedema—Doxorubicin—ovarian cancer	0.000123	0.00029	CcSEcCtD
Lamotrigine—Infection—Doxorubicin—ovarian cancer	0.000122	0.000288	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000121	0.000286	CcSEcCtD
Lamotrigine—Shock—Doxorubicin—ovarian cancer	0.000121	0.000286	CcSEcCtD
Lamotrigine—Nervous system disorder—Doxorubicin—ovarian cancer	0.00012	0.000285	CcSEcCtD
Lamotrigine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00012	0.000284	CcSEcCtD
Lamotrigine—Insomnia—Epirubicin—ovarian cancer	0.00012	0.000284	CcSEcCtD
Lamotrigine—Tachycardia—Doxorubicin—ovarian cancer	0.00012	0.000283	CcSEcCtD
Lamotrigine—Paraesthesia—Epirubicin—ovarian cancer	0.000119	0.000282	CcSEcCtD
Lamotrigine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000119	0.000281	CcSEcCtD
Lamotrigine—Dyspnoea—Epirubicin—ovarian cancer	0.000118	0.00028	CcSEcCtD
Lamotrigine—Somnolence—Epirubicin—ovarian cancer	0.000118	0.000279	CcSEcCtD
Lamotrigine—Anorexia—Doxorubicin—ovarian cancer	0.000117	0.000277	CcSEcCtD
Lamotrigine—Nausea—Docetaxel—ovarian cancer	0.000117	0.000276	CcSEcCtD
Lamotrigine—Dyspepsia—Epirubicin—ovarian cancer	0.000117	0.000276	CcSEcCtD
Lamotrigine—Decreased appetite—Epirubicin—ovarian cancer	0.000115	0.000273	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000114	0.000271	CcSEcCtD
Lamotrigine—Fatigue—Epirubicin—ovarian cancer	0.000114	0.00027	CcSEcCtD
Lamotrigine—Pain—Epirubicin—ovarian cancer	0.000113	0.000268	CcSEcCtD
Lamotrigine—Constipation—Epirubicin—ovarian cancer	0.000113	0.000268	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000112	0.000264	CcSEcCtD
Lamotrigine—Insomnia—Doxorubicin—ovarian cancer	0.000111	0.000263	CcSEcCtD
Lamotrigine—Paraesthesia—Doxorubicin—ovarian cancer	0.00011	0.000261	CcSEcCtD
Lamotrigine—Dyspnoea—Doxorubicin—ovarian cancer	0.000109	0.000259	CcSEcCtD
Lamotrigine—Feeling abnormal—Epirubicin—ovarian cancer	0.000109	0.000259	CcSEcCtD
Lamotrigine—Somnolence—Doxorubicin—ovarian cancer	0.000109	0.000258	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000108	0.000257	CcSEcCtD
Lamotrigine—Dyspepsia—Doxorubicin—ovarian cancer	0.000108	0.000255	CcSEcCtD
Lamotrigine—Decreased appetite—Doxorubicin—ovarian cancer	0.000107	0.000252	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000106	0.000251	CcSEcCtD
Lamotrigine—Fatigue—Doxorubicin—ovarian cancer	0.000106	0.00025	CcSEcCtD
Lamotrigine—Urticaria—Epirubicin—ovarian cancer	0.000105	0.000249	CcSEcCtD
Lamotrigine—Pain—Doxorubicin—ovarian cancer	0.000105	0.000248	CcSEcCtD
Lamotrigine—Constipation—Doxorubicin—ovarian cancer	0.000105	0.000248	CcSEcCtD
Lamotrigine—Abdominal pain—Epirubicin—ovarian cancer	0.000105	0.000248	CcSEcCtD
Lamotrigine—Body temperature increased—Epirubicin—ovarian cancer	0.000105	0.000248	CcSEcCtD
Lamotrigine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000101	0.000239	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.0001	0.000237	CcSEcCtD
Lamotrigine—Hypersensitivity—Epirubicin—ovarian cancer	9.76e-05	0.000231	CcSEcCtD
Lamotrigine—Urticaria—Doxorubicin—ovarian cancer	9.74e-05	0.000231	CcSEcCtD
Lamotrigine—Abdominal pain—Doxorubicin—ovarian cancer	9.69e-05	0.000229	CcSEcCtD
Lamotrigine—Body temperature increased—Doxorubicin—ovarian cancer	9.69e-05	0.000229	CcSEcCtD
Lamotrigine—Asthenia—Epirubicin—ovarian cancer	9.51e-05	0.000225	CcSEcCtD
Lamotrigine—Pruritus—Epirubicin—ovarian cancer	9.38e-05	0.000222	CcSEcCtD
Lamotrigine—Diarrhoea—Epirubicin—ovarian cancer	9.07e-05	0.000215	CcSEcCtD
Lamotrigine—Hypersensitivity—Doxorubicin—ovarian cancer	9.03e-05	0.000214	CcSEcCtD
Lamotrigine—Asthenia—Doxorubicin—ovarian cancer	8.8e-05	0.000208	CcSEcCtD
Lamotrigine—Dizziness—Epirubicin—ovarian cancer	8.76e-05	0.000207	CcSEcCtD
Lamotrigine—Pruritus—Doxorubicin—ovarian cancer	8.68e-05	0.000205	CcSEcCtD
Lamotrigine—Vomiting—Epirubicin—ovarian cancer	8.43e-05	0.000199	CcSEcCtD
Lamotrigine—Diarrhoea—Doxorubicin—ovarian cancer	8.39e-05	0.000199	CcSEcCtD
Lamotrigine—Rash—Epirubicin—ovarian cancer	8.36e-05	0.000198	CcSEcCtD
Lamotrigine—Dermatitis—Epirubicin—ovarian cancer	8.35e-05	0.000198	CcSEcCtD
Lamotrigine—Headache—Epirubicin—ovarian cancer	8.3e-05	0.000197	CcSEcCtD
Lamotrigine—Dizziness—Doxorubicin—ovarian cancer	8.11e-05	0.000192	CcSEcCtD
Lamotrigine—Nausea—Epirubicin—ovarian cancer	7.87e-05	0.000186	CcSEcCtD
Lamotrigine—Vomiting—Doxorubicin—ovarian cancer	7.8e-05	0.000185	CcSEcCtD
Lamotrigine—Rash—Doxorubicin—ovarian cancer	7.73e-05	0.000183	CcSEcCtD
Lamotrigine—Dermatitis—Doxorubicin—ovarian cancer	7.72e-05	0.000183	CcSEcCtD
Lamotrigine—Headache—Doxorubicin—ovarian cancer	7.68e-05	0.000182	CcSEcCtD
Lamotrigine—Nausea—Doxorubicin—ovarian cancer	7.28e-05	0.000172	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—MMP2—ovarian cancer	2e-05	0.0019	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MMP2—ovarian cancer	2e-05	0.0019	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—VEGFA—ovarian cancer	1.97e-05	0.00187	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—MAPK3—ovarian cancer	1.95e-05	0.00185	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—NRAS—ovarian cancer	1.94e-05	0.00185	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MMP2—ovarian cancer	1.93e-05	0.00184	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MMP2—ovarian cancer	1.93e-05	0.00184	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—ERBB2—ovarian cancer	1.91e-05	0.00181	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MMP2—ovarian cancer	1.9e-05	0.00181	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—VEGFA—ovarian cancer	1.89e-05	0.0018	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—VEGFA—ovarian cancer	1.89e-05	0.0018	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—NRAS—ovarian cancer	1.87e-05	0.00178	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—NRAS—ovarian cancer	1.87e-05	0.00178	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—MAPK3—ovarian cancer	1.86e-05	0.00177	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—MAPK1—ovarian cancer	1.85e-05	0.00176	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—EGFR—ovarian cancer	1.85e-05	0.00176	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—HRAS—ovarian cancer	1.84e-05	0.00175	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	1.83e-05	0.00174	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—ERBB2—ovarian cancer	1.82e-05	0.00174	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—VEGFA—ovarian cancer	1.82e-05	0.00174	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—VEGFA—ovarian cancer	1.82e-05	0.00174	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—VEGFA—ovarian cancer	1.82e-05	0.00173	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—NRAS—ovarian cancer	1.8e-05	0.00171	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—NRAS—ovarian cancer	1.8e-05	0.00171	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—STAT3—ovarian cancer	1.8e-05	0.00171	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—NRAS—ovarian cancer	1.79e-05	0.00171	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—MAPK3—ovarian cancer	1.79e-05	0.0017	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—MAPK3—ovarian cancer	1.79e-05	0.0017	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—MAPK1—ovarian cancer	1.77e-05	0.00169	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—EGFR—ovarian cancer	1.77e-05	0.00169	CbGpPWpGaD
Lamotrigine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	1.77e-05	0.00168	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—IL6—ovarian cancer	1.76e-05	0.00168	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—ERBB2—ovarian cancer	1.75e-05	0.00167	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—ERBB2—ovarian cancer	1.75e-05	0.00167	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—KRAS—ovarian cancer	1.75e-05	0.00167	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—YAP1—ovarian cancer	1.73e-05	0.00165	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MAPK3—ovarian cancer	1.73e-05	0.00164	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—MAPK3—ovarian cancer	1.73e-05	0.00164	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—MAPK3—ovarian cancer	1.72e-05	0.00163	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	1.71e-05	0.00163	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—MAPK1—ovarian cancer	1.7e-05	0.00162	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—MAPK1—ovarian cancer	1.7e-05	0.00162	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—EGFR—ovarian cancer	1.7e-05	0.00162	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—EGFR—ovarian cancer	1.7e-05	0.00162	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—ERBB2—ovarian cancer	1.69e-05	0.00161	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—ERBB2—ovarian cancer	1.69e-05	0.00161	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—KRAS—ovarian cancer	1.67e-05	0.00159	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—CTNNB1—ovarian cancer	1.67e-05	0.00159	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—ERBB2—ovarian cancer	1.66e-05	0.00158	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—MAPK1—ovarian cancer	1.64e-05	0.00156	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MAPK1—ovarian cancer	1.64e-05	0.00156	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—EGFR—ovarian cancer	1.64e-05	0.00156	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—EGFR—ovarian cancer	1.64e-05	0.00156	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—MMP9—ovarian cancer	1.64e-05	0.00156	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—MAPK1—ovarian cancer	1.63e-05	0.00156	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—EGFR—ovarian cancer	1.63e-05	0.00156	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MET—ovarian cancer	1.63e-05	0.00155	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	1.61e-05	0.00154	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—KRAS—ovarian cancer	1.61e-05	0.00153	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—KRAS—ovarian cancer	1.61e-05	0.00153	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—CTNNB1—ovarian cancer	1.6e-05	0.00152	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—IL6ST—ovarian cancer	1.59e-05	0.00152	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—IL6—ovarian cancer	1.59e-05	0.00151	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—MMP9—ovarian cancer	1.56e-05	0.00149	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—KRAS—ovarian cancer	1.55e-05	0.00148	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—KRAS—ovarian cancer	1.55e-05	0.00148	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	1.55e-05	0.00147	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	1.54e-05	0.00147	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—CASP3—ovarian cancer	1.54e-05	0.00147	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—KRAS—ovarian cancer	1.54e-05	0.00147	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—IL2—ovarian cancer	1.54e-05	0.00147	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—CTNNB1—ovarian cancer	1.53e-05	0.00146	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—CTNNB1—ovarian cancer	1.53e-05	0.00146	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	1.51e-05	0.00144	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MMP9—ovarian cancer	1.5e-05	0.00143	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MMP9—ovarian cancer	1.5e-05	0.00143	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	1.5e-05	0.00143	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—HRAS—ovarian cancer	1.49e-05	0.00142	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	1.48e-05	0.00141	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—CTNNB1—ovarian cancer	1.48e-05	0.00141	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—CTNNB1—ovarian cancer	1.48e-05	0.00141	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	1.47e-05	0.0014	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—VEGFA—ovarian cancer	1.47e-05	0.0014	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—STAT3—ovarian cancer	1.45e-05	0.00138	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—NRAS—ovarian cancer	1.45e-05	0.00138	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MMP9—ovarian cancer	1.45e-05	0.00138	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MMP9—ovarian cancer	1.45e-05	0.00138	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—YAP1—ovarian cancer	1.44e-05	0.00137	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MMP9—ovarian cancer	1.43e-05	0.00136	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—IL6—ovarian cancer	1.42e-05	0.00135	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—HRAS—ovarian cancer	1.42e-05	0.00135	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—FASN—ovarian cancer	1.41e-05	0.00134	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—VEGFA—ovarian cancer	1.4e-05	0.00134	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—STAT3—ovarian cancer	1.39e-05	0.00132	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—MAPK3—ovarian cancer	1.39e-05	0.00132	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—SLC5A5—ovarian cancer	1.39e-05	0.00132	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—NRAS—ovarian cancer	1.39e-05	0.00132	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—HRAS—ovarian cancer	1.37e-05	0.0013	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—HRAS—ovarian cancer	1.37e-05	0.0013	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—IL6—ovarian cancer	1.36e-05	0.0013	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MMP2—ovarian cancer	1.36e-05	0.00129	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—VEGFA—ovarian cancer	1.35e-05	0.00128	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—VEGFA—ovarian cancer	1.35e-05	0.00128	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—SLC2A1—ovarian cancer	1.34e-05	0.00128	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—STAT3—ovarian cancer	1.34e-05	0.00127	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—STAT3—ovarian cancer	1.34e-05	0.00127	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—NRAS—ovarian cancer	1.33e-05	0.00127	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—NRAS—ovarian cancer	1.33e-05	0.00127	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—MAPK3—ovarian cancer	1.33e-05	0.00126	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—MAPK1—ovarian cancer	1.32e-05	0.00126	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—EGFR—ovarian cancer	1.32e-05	0.00126	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—HRAS—ovarian cancer	1.32e-05	0.00125	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—HRAS—ovarian cancer	1.32e-05	0.00125	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—HRAS—ovarian cancer	1.31e-05	0.00125	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	1.31e-05	0.00125	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—IL6—ovarian cancer	1.31e-05	0.00124	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—IL6—ovarian cancer	1.31e-05	0.00124	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—VEGFA—ovarian cancer	1.3e-05	0.00124	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—VEGFA—ovarian cancer	1.3e-05	0.00124	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—STAT3—ovarian cancer	1.29e-05	0.00123	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—STAT3—ovarian cancer	1.29e-05	0.00123	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—CYP1B1—ovarian cancer	1.29e-05	0.00122	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—NRAS—ovarian cancer	1.29e-05	0.00122	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—NRAS—ovarian cancer	1.29e-05	0.00122	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—VEGFA—ovarian cancer	1.28e-05	0.00122	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MAPK3—ovarian cancer	1.28e-05	0.00122	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MAPK3—ovarian cancer	1.28e-05	0.00122	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—NRAS—ovarian cancer	1.27e-05	0.00121	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—MAPK1—ovarian cancer	1.26e-05	0.0012	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—EGFR—ovarian cancer	1.26e-05	0.0012	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—IL6—ovarian cancer	1.26e-05	0.0012	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—IL6—ovarian cancer	1.26e-05	0.0012	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—IL6—ovarian cancer	1.26e-05	0.0012	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—KRAS—ovarian cancer	1.25e-05	0.00119	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MAPK3—ovarian cancer	1.23e-05	0.00117	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MAPK3—ovarian cancer	1.23e-05	0.00117	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MAPK1—ovarian cancer	1.21e-05	0.00116	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MAPK1—ovarian cancer	1.21e-05	0.00116	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—EGFR—ovarian cancer	1.21e-05	0.00116	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—EGFR—ovarian cancer	1.21e-05	0.00116	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MAPK3—ovarian cancer	1.21e-05	0.00115	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—NME2—ovarian cancer	1.21e-05	0.00115	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—KRAS—ovarian cancer	1.19e-05	0.00114	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—ERBB2—ovarian cancer	1.19e-05	0.00113	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—FASN—ovarian cancer	1.17e-05	0.00112	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MAPK1—ovarian cancer	1.17e-05	0.00111	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MAPK1—ovarian cancer	1.17e-05	0.00111	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—EGFR—ovarian cancer	1.17e-05	0.00111	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—EGFR—ovarian cancer	1.17e-05	0.00111	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.17e-05	0.00111	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—AKT1—ovarian cancer	1.16e-05	0.0011	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—SLC5A5—ovarian cancer	1.15e-05	0.0011	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MAPK1—ovarian cancer	1.15e-05	0.0011	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—EGFR—ovarian cancer	1.15e-05	0.0011	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—KRAS—ovarian cancer	1.15e-05	0.00109	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—KRAS—ovarian cancer	1.15e-05	0.00109	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	1.14e-05	0.00109	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PPP2R1A—ovarian cancer	1.14e-05	0.00109	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—SLC2A1—ovarian cancer	1.11e-05	0.00106	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—KRAS—ovarian cancer	1.11e-05	0.00105	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—KRAS—ovarian cancer	1.11e-05	0.00105	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—KRAS—ovarian cancer	1.09e-05	0.00104	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.08e-05	0.00103	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—CYP1B1—ovarian cancer	1.07e-05	0.00102	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—HRAS—ovarian cancer	1.06e-05	0.00101	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—ABCB1—ovarian cancer	1.06e-05	0.00101	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—TYMS—ovarian cancer	1.04e-05	0.00099	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—CTNNB1—ovarian cancer	1.04e-05	0.000989	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MMP9—ovarian cancer	1.02e-05	0.00097	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—IL6—ovarian cancer	1.02e-05	0.000967	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—HRAS—ovarian cancer	1.02e-05	0.000966	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—HRAS—ovarian cancer	9.75e-06	0.000928	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—HRAS—ovarian cancer	9.75e-06	0.000928	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—IL6—ovarian cancer	9.71e-06	0.000925	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	9.65e-06	0.000919	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PPP2R1A—ovarian cancer	9.48e-06	0.000902	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—HRAS—ovarian cancer	9.4e-06	0.000895	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—HRAS—ovarian cancer	9.4e-06	0.000895	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—AKT1—ovarian cancer	9.37e-06	0.000892	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—IL6—ovarian cancer	9.33e-06	0.000888	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—IL6—ovarian cancer	9.33e-06	0.000888	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—HRAS—ovarian cancer	9.26e-06	0.000882	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—VEGFA—ovarian cancer	9.15e-06	0.000871	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—STAT3—ovarian cancer	9.06e-06	0.000862	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—NRAS—ovarian cancer	9.04e-06	0.00086	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—IL6—ovarian cancer	9e-06	0.000857	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—IL6—ovarian cancer	9e-06	0.000857	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—AKT1—ovarian cancer	8.96e-06	0.000853	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—IL6—ovarian cancer	8.87e-06	0.000844	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—ABCB1—ovarian cancer	8.8e-06	0.000838	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MAPK3—ovarian cancer	8.65e-06	0.000824	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—TYMS—ovarian cancer	8.64e-06	0.000823	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—AKT1—ovarian cancer	8.61e-06	0.00082	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—AKT1—ovarian cancer	8.61e-06	0.00082	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	8.4e-06	0.000799	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—CAV1—ovarian cancer	8.38e-06	0.000797	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—AKT1—ovarian cancer	8.3e-06	0.00079	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—AKT1—ovarian cancer	8.3e-06	0.00079	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MAPK1—ovarian cancer	8.23e-06	0.000784	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—EGFR—ovarian cancer	8.23e-06	0.000784	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.81e-06	0.000743	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—CYTB—ovarian cancer	7.78e-06	0.000741	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—KRAS—ovarian cancer	7.78e-06	0.00074	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	7.77e-06	0.00074	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PIK3CG—ovarian cancer	7.63e-06	0.000726	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	7.62e-06	0.000725	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.54e-06	0.000718	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	7.42e-06	0.000706	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	7.35e-06	0.000699	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	7.16e-06	0.000681	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—CAV1—ovarian cancer	6.96e-06	0.000663	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PPP1CC—ovarian cancer	6.8e-06	0.000647	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—BRIP1—ovarian cancer	6.8e-06	0.000647	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PIK3CD—ovarian cancer	6.71e-06	0.000639	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—HRAS—ovarian cancer	6.61e-06	0.000629	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	6.47e-06	0.000615	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PIK3CG—ovarian cancer	6.34e-06	0.000604	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—IL6—ovarian cancer	6.33e-06	0.000602	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	6.12e-06	0.000582	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	5.95e-06	0.000566	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PIK3CB—ovarian cancer	5.85e-06	0.000557	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—AKT1—ovarian cancer	5.84e-06	0.000556	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	5.82e-06	0.000554	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	5.82e-06	0.000554	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PIK3CD—ovarian cancer	5.58e-06	0.000531	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	5.5e-06	0.000523	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PTEN—ovarian cancer	5.05e-06	0.000481	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	5.05e-06	0.000481	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	4.89e-06	0.000465	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PIK3CB—ovarian cancer	4.86e-06	0.000463	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—YAP1—ovarian cancer	4.56e-06	0.000434	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PTEN—ovarian cancer	4.2e-06	0.0004	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	4.13e-06	0.000393	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—FASN—ovarian cancer	3.72e-06	0.000354	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—SLC5A5—ovarian cancer	3.66e-06	0.000348	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PIK3CA—ovarian cancer	3.56e-06	0.000339	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—SLC2A1—ovarian cancer	3.53e-06	0.000336	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—CYP1B1—ovarian cancer	3.39e-06	0.000322	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	3e-06	0.000286	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PIK3CA—ovarian cancer	2.96e-06	0.000282	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—AKT1—ovarian cancer	2.91e-06	0.000277	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—TYMS—ovarian cancer	2.74e-06	0.000261	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—AKT1—ovarian cancer	2.42e-06	0.00023	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—CAV1—ovarian cancer	2.21e-06	0.00021	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.01e-06	0.000191	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PIK3CD—ovarian cancer	1.77e-06	0.000168	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.54e-06	0.000147	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PTEN—ovarian cancer	1.33e-06	0.000127	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PIK3CA—ovarian cancer	9.39e-07	8.94e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—AKT1—ovarian cancer	7.67e-07	7.3e-05	CbGpPWpGaD
